The test examines genetic variants in metabolic pathways (FTO, MC4R, GLP1R, GIPR) that relate to weight regulation and glucose control
Living with T1D means we learn to adjust our insulin and food intake based on the reaction these activities have on our blood glucose levels
Further reported systemic complications include renal infarction and rhabdomyolysis
Common symptoms include: Persistent worry or a sense of dread thats hard to switch off Restlessness and difficulty relaxing Difficulty concentrating or mind going blank Sleep problems, including trouble falling or staying asleep Physical symptoms like rapid heartbeat, sweating, muscle tension, and stomach problems Irritability Avoidance of situations that trigger anxiety Anxiety is treatable
GLP-1 S is a research-driven platform focused on advancements in metabolic science and GLP-1based peptide compounds
Average time from intake submission to first video visit on national platforms averaged 23 hours in West Virginia as of Q4 2025, slightly longer than national average due to clinician supply